Listed by the USPTO as EDOUARD, JONATHAN CHRISTOPHER
Tech Center 3600 • Art Units: 3626 3683
This examiner grants 24% of resolved cases
Jonathan Christopher Edouard is an examiner in Tech Center 3600 and Art Unit 3626. He has 59 resolved cases. The allowance rate for these cases is 23.7 percent. The median time to allowance is 1181 days. This 1181-day timeline informs the expected duration of the prosecution process for applications that reach a grant. The 23.7 percent baseline helps practitioners estimate the likelihood of a successful outcome in this docket.
The interview lift is 39.0 percent. This 39.0 percent increase suggests that oral advocacy is an effective tool for overcoming rejections. Practitioners can use this metric to justify the time and resources required for an interview. Top companies in this docket include NEC Corporation, Cilag GmbH International, and Abbott Laboratories. These companies are often represented by firms such as PROCOPIO, CORY, HARGREAVES & SAVITCH LLP, SCHWEGMAN LUNDBERG & WOESSNER, P.A., and TAROLLI, SUNDHEIM, COVELL & TUMMINO L.L.P. These firms manage cases through the 1181-day median pendency to reach the 23.7 percent allowance rate. The 59 resolved cases provide a data set for evaluating examination trends in Art Unit 3626.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19057023 | TEST ASSIST APPARATUS, TEST ASSIST METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 18452928 | SURGICAL SYSTEMS WITH INTERACTIVE HANDLING AND DISPOSAL GUIDANCE | Final Rejection | Cilag GmbH International |
| 18443390 | IMAGE REGISTRATIONS WITH AUTOMATIC SPINAL ALIGNMENT MEASUREMENT | Non-Final OA | GLOBUS MEDICAL, INC. |
| 17516740 | DETERMINING INFECTION RISK LEVELS | Non-Final OA | International Business Machines Corporation |
| 18649578 | REMOTE PATIENT MONITORING AND CARE COORDINATION PLATFORM TO SUPPORT HYPERTENSION CARE OPTIMIZATION | Non-Final OA | Medtronic Ireland Manufacturing Unlimited Company |
| 19469620 | IMAGE ANALYTICS FOR CHARTING | Non-Final OA | ZOLL Medical Corporation |
| 18897717 | MEDICAL SUPPORT DEVICE | Final Rejection | NIHON KOHDEN CORPORATION |
| 18002075 | SYSTEMS AND METHODS FOR EVALUATING A SUBJECT FOR INFLAMMATORY BOWEL DISEASE MANAGEMENT | Final Rejection | Icahn School of Medicine at Mount Sinai |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy23.7% of resolved applications examined by Jonathan Christopher Edouard were allowed (59 resolved cases), compared with 24.6% across Art Unit 3626 over the last five years.
This examiner's interview lift is +39.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jonathan Christopher Edouard took 1,181 days on average from filing to allowance.
Jonathan Christopher Edouard examines applications in Art Unit 3626 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).
